Search Login Register

Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide)) Summary

Description: A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE).

Also Known As: VIP (Vasoactive Intestinal Peptide); Vasointestinal Peptide; Vasoactive Intestinal Polypeptide; Intestinal Peptide, Vasoactive; Intestinal Polypeptide, Vasoactive Show All >>

Networked: 1690 relevant articles (23 outcomes, 162 trials/studies) for this Bio-Agent

Key Diseases for which Vasoactive Intestinal Peptide is Relevant

  1. Neoplasms (Cancer) : 5 outcomes 11 studies in 269 results
  2. Colitis : 3 outcomes 4 studies in 19 results
  3. Ganglion Cysts (Ganglion) : 2 outcomes 13 studies in 142 results
  4. Asthma (Bronchial Asthma) : 2 outcomes 1 study in 26 results
  5. Septic Shock (Toxic Shock Syndrome) : 2 outcomes in 8 results
Show All >>

Drugs Related to Vasoactive Intestinal Peptide

  1. Substance P
  2. Calcitonin Gene-Related Peptide
  3. Octreotide (Sandostatin)
  4. Neuropeptides
  5. Somatostatin (Somatotropin Release-Inhibiting Factor)
  6. Neuropeptide Y
  7. Serotonin (5 Hydroxytryptamine)
  8. Bombesin
  9. Phosphopyruvate Hydratase (Enolase)
  10. Antibodies
Show All >>

Therapies Related to Vasoactive Intestinal Peptide

  1. Denervation
  2. Lung Transplantation
  3. Electroacupuncture
  4. Axotomy
  5. Aftercare (After-Treatment)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.